• Fatty liver disease 'does not increase risk of death'

Solid Phase Extraction (SPE)

Fatty liver disease 'does not increase risk of death'

Nov 25 2011

Non-alcoholic fatty liver disease (NAFLD) does not affect the long-term survival of sufferers, as previously thought, according to new research.

Scientists at John Hopkins School of Medicine successfully used solid phase extraction data to assess enzyme and substrate levels associated with NAFLD in over 11,000 patients.

The findings, published in the British Medical Journal, show no increase in mortality among those diagnosed with NAFLD, which was identified in around 20 per cent of the participants.

Study leader Mariana Lazo explained that the data did not show NAFLD to be a risk factor for cardiovascular disease.

"We were surprised to say the least because we expected to learn by how much non-alcoholic fatty liver disease increased the risk of death and instead found the answer was not at all," she added.

However, Ms Lazo indicated further research would be needed to determine if advanced variations of the condition pose more serious consequences.

Posted by Fiona Griffiths

Digital Edition

Chromatography Today - Buyers' Guide 2022

October 2023

In This Edition Modern & Practical Applications - Accelerating ADC Development with Mass Spectrometry - Implementing High-Resolution Ion Mobility into Peptide Mapping Workflows Chromatogr...

View all digital editions


EuCheMS Chemistry Congress

Jul 07 2024 Dublin, Ireland

HPLC 2024

Jul 20 2024 Denver, CO, USA

ICMGP 2024

Jul 21 2024 Cape Town, South Africa

ACS National Meeting - Fall 2024

Aug 18 2024 Denver, CO, USA

JASIS 2024

Sep 04 2024 Chiba, Tokyo, Japan

View all events